Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

Topics
Activity report
Results
Acknowledgement

2025.03.06: The 5^th KENTO Co-Creation Forum was held.
2025.02.26: The 14^th Steering Committee meeting was held, and progress was shared with all members.
2025.02.19: As part of our support for startup creation/ growth promotion, we held the 5^th Startup Seminar
2025.02.17: As part of our support for startup creation/growth promotion, we held a Startup Seminar (special edition).
2025.02.13-16: We exhibited at the EXPO 2025 pre-event " Science : Connecting You to the Future."
2025.02.03,05: We held the final year report session for the Startup Creation/Growth Promotion Support Program.
2025.01.14: We held the PI Development Program Progress Report General Meeting.
2024.12.05: We held a joint symposium with the Tsukuba Digital-Bio International Center.
2024.12.02: The brochure for our base has been completed.
2024.11.25: As part of our support for startup creation/ growth promotion, we held the 4th Startup Seminar

Report on the Startup Support Seminar [5th]

On Wednesday, February 19^th, we held the 5^th Startup Support Seminar. This time, we had a lecture by Daisuke Morishita of Chordia Therapeutics Inc., titled "The Reality of Listing a Drug Discovery Startup".
From his perspective as an experienced entrepreneur, he discussed the reality of listing a drug discovery startup, discussing the difficulties and issues unique to drug discovery startups.

We would like to thank all of you for attending.

Please look forward to future seminars.

◆ Report on the Startup Support Seminar [5th]
The Reality of Listing a Drug Discovery Startup
· Day and time : Wednesday February 19^th 18:00-19:30
· Venue : LINK-J WEST

· Speakers :: (Moderator)
Cabinet Office Bioeconomy Strategy Expert/LSIC Organizer, Lawyer
Nao Yoshizawa
(Speakers)
Chief Scientific Officer, Chordia Therapeutics Inc. Daisuke Morishita

Report on the Startup Support Seminar [Special Edition]

On Monday, February 17^th, we held the "Startup Support Seminar [Special Edition]". This time, the seminar was titled "Hybrid Seminar for the Application of AI in the life science sector," and speakers gave presentations on the current state and challenges of AI use, as well as implementation examples. We would like to thank the many people who participated both in person and online.

We hope you will join us in future seminars.

◆ JST COI-NEXT Program × Life Science Incubation Council [Special Edition]
Hybrid Seminar for the Application of AI in the life science sector
· Date and time : Monday, February 17^th 17:30-20:00
· Venue : Ochanomizu Sola City

· Speakers :: Soichiro Imaeda/Vice Minister of Education, Science & Technology
Mr. Nao Yoshizawa, Founder, Life Science Incubation Council
KPMG Consulting Co., Ltd., Mr. Seigo Hara
Cambridge Consultants Co., Ltd., Mr. Takuya Matsui
Oracle Japan, Mr. Yusuke Matsui
Juntendo University, Mr. Tamaki Nara
University College London, Institute of Ophthalmology and Moorfield’s Eye Hospital, Professor Pearse Keane
Professor of Drug Discovery Pharma & Bio Chemistry UCL School of Pharmacy, Professor Matthew Todd
Thermo Fisher Scientific, Dr. Natraj Ram

EXPO 2025 pre-event " Science : Connecting You to the Future. "

We exhibited at the Osaka Kansai EXPO Pre-Event "Connecting You to the Future, Science Exhibition" (Tokyo Innovation Base), held from February 13^th to 16^th. At our base, we exhibited Danionella cerebrum handled by the Kento Imaging Support Center and the National Cardiovascular Center Department of Cardiac Regeneration Biology, entitled "The New World of Microscopic Imaging: Danionella cerebrum".
Many people, including families and base personnel, stopped by to see the exhibit.
The actual event will be held from August 14th to 19th at the EXPO Messe (Yumeshima) in the Osaka Kansai EXPO site.

If you are visiting the Expo, please stop by!

Report on the PI Development Program Progress Report General Meeting

On Tuesday, January 14^th, the nine PI Development Program recipients, organizers, and recommenders gathered on-site to hold a progress report meeting (general meeting).The organizers gave advice to each recipient‘s presentation, and lively discussions were held.
This time, there was also advice from two recipients of the Japan Science and Technology Agency (JST) and the Japan Advanced Research and Development Agency (AMED-PRIME) programs, and the discussion was held to deepen strategies for obtaining competitive funding in the future.

We will continue to actively support recipients in the future.

Scene from the venue

2024.11.11: The following press release was issued by project leader Mochizuki Naoki and Yamagata University School of Medicine.
Zonated Wnt/β-catenin signal-activated cardiomyocytes at the atrioventricular canal promote coronary vessel formation in zebrafish
2024.09.19: There was a press release on the study of Dr. Takahisa Furukawa, the leader of R&D theme 5.
Ccrk-Mak/Ick signaling is a ciliary transport regulator essential for retinal photoreceptor survival
2024.09.17: Nobuhiro Nakai (Kobe University), a recipient of the PI Development Program, has been selected for the FY2024 “Advanced Research ＆ Development Programs for Medical (AMED-PRIME)”. (in Japanese only.)
2024.08.28: There was a press release on the study of Dr. Hiroshi Seno, the leader of R&D theme 2.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
2024.06.25: Atsushi Mitsuhashi (Tokushima University), a recipient of the PI Development Program, has been selected for the FY2023 “ Fusion oriented Research for disruptive Science and Technology (JST). (in Japanese only.)
2022.10.25: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070